Updated axial SpA recommendations include IL-17 inhibitors

LONDON – The option of treating axial spondyloarthritis with an interleukin-17 inhibitor has become an officially recommended option for the first time in a new update to management recommendations...
Source: Hospitalist News - Category: Hospital Management Source Type: research